uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Global expression variability of proteins across and within human tissues
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Uppsala University. (Läkemedelsformulering)ORCID iD: 0000-0002-2810-7518
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. (Läkemedelsformulering)ORCID iD: 0000-0002-4502-8184
Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Uppsala University, Science for Life Laboratory, SciLifeLab. (Läkemedelsformulering)
Show others and affiliations
(English)In: Article in journal (Other academic) Submitted
Place, publisher, year, edition, pages
Uppsala.
Keywords [en]
Expression variability, Human liver, Human jejunum, Proteomics, Transcriptomics, Reference genes
National Category
Cell and Molecular Biology
Research subject
Pharmaceutical Science
Identifiers
URN: urn:nbn:se:uu:diva-389738OAI: oai:DiVA.org:uu-389738DiVA, id: diva2:1338497
Available from: 2019-07-23 Created: 2019-07-23 Last updated: 2019-07-26
In thesis
1. Proteomics-informed analysis of drug disposition in the human liver and small intestine
Open this publication in new window or tab >>Proteomics-informed analysis of drug disposition in the human liver and small intestine
2019 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Orally administered drugs are absorbed in the intestine and generally metabolized in the liver. Therefore, understanding factors determining drug distribution and elimination in these tissues is important. This thesis aimed at using mass spectrometry (MS)-based proteomics and functional studies to better understand in vitro model systems used for drug clearance predictions. Further, it aimed at understanding the changes in drug disposition caused by obesity and gastric bypass surgery (GBP).

The study was initiated by investigating factors influencing MS-based protein quantification by comparing results from different proteomics methods, and by studying protein distribution during subcellular fractionation. The largest variability in protein quantification was ascribed to insufficient enrichment from subcellular fractionation, most likely due to collection of the majority of the proteins in the initial fraction of the fractionation protocols.

Proteomics and metabolic activity analyses were then used to investigate differences in intrinsic clearance from two commonly used in vitro systems, human liver microsomes and hepatocytes. For some compounds, the faster microsomal metabolism could be explained by a higher available unbound drug concentration and CYP content in the microsomes as compared to in the hepatocytes.

Next, inter-individual protein expression variability in human liver and jejunum was explored. This showed that proteins covered a wide inter-individual variability spectrum, in which proteins with low variabilities were associated with essential cellular functions, while many proteins with high variabilities were disease-related.

Further, the effects of obesity, GBP, and weight loss on the proteomes of human liver and jejunum were analyzed. After GBP and subsequent weight loss, patients showed lower levels of jejunal proteins involved in inflammatory response and drug metabolism.

Finally, proteomics data from patients with and without obesity was combined with parameters from in vitro transport kinetics, and a mechanistic model to predict drug disposition was developed. The model successfully predicted rosuvastatin plasma concentrations in the patients.

In conclusion, this thesis has provided insights into factors influencing protein quantification and function in vitro. Furthermore, this thesis demonstrates how proteomics contributes to improved understanding of inter-individual and physiological differences, and how it can be used for in vitro-in vivo scaling of drug clearance.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2019. p. 79
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 273
Keywords
proteomics, protein concentration, drug disposition, drug transport, drug metabolism, human small intestine, human liver, human hepatocytes, human liver microsomes, inter-individual variability, drug clearance, obesity, prediction model
National Category
Pharmaceutical Sciences
Research subject
Pharmaceutical Science
Identifiers
urn:nbn:se:uu:diva-389741 (URN)978-91-513-0694-0 (ISBN)
Public defence
2019-09-13, B42, Biomedical center, Husargatan 3, Uppsala, 09:15 (English)
Opponent
Supervisors
Available from: 2019-08-22 Created: 2019-07-26 Last updated: 2019-08-22

Open Access in DiVA

No full text in DiVA

Authority records BETA

Wegler, ChristineÖlander, MagnusLundquist, PatrikArtursson, Per

Search in DiVA

By author/editor
Wegler, ChristineÖlander, MagnusLundquist, PatrikArtursson, Per
By organisation
Department of PharmacyScience for Life Laboratory, SciLifeLab
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 23 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf